Corrigendum: <i>CDKN2A</i> determines mesothelioma cell fate to EZH2 inhibition.

Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition.

Pinton, Giulia; Wang, Zhuo; Balzano, Cecilia; Missaglia, Sara; Tavian, Daniela; Boldorini, Renzo; Fennell, Dean A; Griffin, Martin; Moro, Laura.

Afiliação

Pinton G; Department of Pharmaceutical Sciences, University of Piemonte Orientale (UPO), Novara, Italy.
Wang Z; School of Life and Health Sciences, Aston University, Birmingham, United Kingdom.
Balzano C; Department of Pharmaceutical Sciences, University of Piemonte Orientale (UPO), Novara, Italy.
Missaglia S; Laboratory of Cellular Biochemistry and Molecular Biology, Centro di Ricerca in Biochimica E Nutrizione dello Sport (CRIBENS), Catholic University of the Sacred Heart, Milan, Italy.
Tavian D; Laboratory of Cellular Biochemistry and Molecular Biology, Centro di Ricerca in Biochimica E Nutrizione dello Sport (CRIBENS), Catholic University of the Sacred Heart, Milan, Italy.
Boldorini R; Department of Health Science, University of Piemonte Orientale (UPO), Novara, Italy.
Fennell DA; Leicester Cancer Research Centre, University of Leicester, Leicester, United Kingdom.
Griffin M; School of Life and Health Sciences, Aston University, Birmingham, United Kingdom.
Moro L; Department of Pharmaceutical Sciences, University of Piemonte Orientale (UPO), Novara, Italy.